Literature DB >> 12821620

Canadian consensus guidelines for the management of pregnancy, labour and delivery and for postpartum care in HIV-positive pregnant women and their offspring (summary of 2002 guidelines).

David R Burdge1, Deborah M Money, John C Forbes, Sharon L Walmsley, Fiona M Smaill, Marc Boucher, Lindy M Samson, Marc Steben.   

Abstract

Entities:  

Mesh:

Year:  2003        PMID: 12821620      PMCID: PMC161612     

Source DB:  PubMed          Journal:  CMAJ        ISSN: 0820-3946            Impact factor:   8.262


× No keyword cloud information.
  9 in total

1.  Editorial response: hyperlactatemia and hepatic steatosis as features of mitochondrial toxicity of nucleoside analogue reverse transcriptase inhibitors.

Authors:  K Brinkman
Journal:  Clin Infect Dis       Date:  2000-07-26       Impact factor: 9.079

2.  Canadian consensus guidelines for the care of HIV-positive pregnant women: putting recommendations into practice.

Authors:  David R Burdge; Deborah M Money; John C Forbes; Sharon L Walmsley; Fiona M Smaill; Marc Boucher; Lindy M Samson; Marc Steben
Journal:  CMAJ       Date:  2003-06-24       Impact factor: 8.262

3.  Prevention of vertical HIV transmission: additive protective effect of elective Cesarean section and zidovudine prophylaxis. Swiss Neonatal HIV Study Group.

Authors:  C Kind; C Rudin; C A Siegrist; C A Wyler; K Biedermann; U Lauper; O Irion; J Schüpbach; D Nadal
Journal:  AIDS       Date:  1998-01-22       Impact factor: 4.177

4.  The mode of delivery and the risk of vertical transmission of human immunodeficiency virus type 1--a meta-analysis of 15 prospective cohort studies.

Authors:  W Andiman; Y Bryson; M de Martino; M Fowler; D Harris; C Hutto; B Korber; A Kovacs; S Landesman; M Lindsay; N Lapointe; L Mandelbrot; M-L Newell; H Peavy; J Read; C Rudin; A Semprini; R Simonds; R Tuomala
Journal:  N Engl J Med       Date:  1999-04-01       Impact factor: 91.245

5.  Elective caesarean-section versus vaginal delivery in prevention of vertical HIV-1 transmission: a randomised clinical trial.

Authors: 
Journal:  Lancet       Date:  1999-03-27       Impact factor: 79.321

6.  Potential risk factors for vertical HIV-1 transmission in Catalonia, Spain: the protective role of cesarean section. The Working Group on HIV-1 Vertical Transmission in Catalonia.

Authors:  A Maguire; E Sánchez; C Fortuny; J Casabona
Journal:  AIDS       Date:  1997-12       Impact factor: 4.177

7.  The incidence of complications after caesarean section in 156 HIV-positive women.

Authors:  A E Semprini; C Castagna; M Ravizza; S Fiore; V Savasi; M L Muggiasca; E Grossi; B Guerra; C Tibaldi; G Scaravelli
Journal:  AIDS       Date:  1995-08       Impact factor: 4.177

8.  Caesarean section and risk of vertical transmission of HIV-1 infection. The European Collaborative Study.

Authors: 
Journal:  Lancet       Date:  1994-06-11       Impact factor: 79.321

9.  Perinatal HIV-1 transmission: interaction between zidovudine prophylaxis and mode of delivery in the French Perinatal Cohort.

Authors:  L Mandelbrot; J Le Chenadec; A Berrebi; A Bongain; J L Bénifla; J F Delfraissy; S Blanche; M J Mayaux
Journal:  JAMA       Date:  1998-07-01       Impact factor: 56.272

  9 in total
  11 in total

1.  Canadian consensus guidelines for the care of HIV-positive pregnant women: putting recommendations into practice.

Authors:  David R Burdge; Deborah M Money; John C Forbes; Sharon L Walmsley; Fiona M Smaill; Marc Boucher; Lindy M Samson; Marc Steben
Journal:  CMAJ       Date:  2003-06-24       Impact factor: 8.262

2.  Use of antiretrovirals in newborns.

Authors:  Joan L Robinson
Journal:  CMAJ       Date:  2003-10-28       Impact factor: 8.262

3.  Evidence-based clinical guidelines for immigrants and refugees.

Authors:  Kevin Pottie; Christina Greenaway; John Feightner; Vivian Welch; Helena Swinkels; Meb Rashid; Lavanya Narasiah; Laurence J Kirmayer; Erin Ueffing; Noni E MacDonald; Ghayda Hassan; Mary McNally; Kamran Khan; Ralf Buhrmann; Sheila Dunn; Arunmozhi Dominic; Anne E McCarthy; Anita J Gagnon; Cécile Rousseau; Peter Tugwell
Journal:  CMAJ       Date:  2010-06-07       Impact factor: 8.262

Review 4.  Treatment of HIV infection in pregnant women: antiretroviral management options.

Authors:  Mona R Loutfy; Sharon L Walmsley
Journal:  Drugs       Date:  2004       Impact factor: 9.546

5.  Pharmacologic and nonpharmacologic options for the management of HIV infection during pregnancy.

Authors:  Carmen D Zorrilla; Vivian Tamayo-Agrait
Journal:  HIV AIDS (Auckl)       Date:  2009-12-08

6.  No association between early antiretroviral therapy during pregnancy and plasma levels of angiogenic factors: a cohort study.

Authors:  Ameyo Djeha; Sylvie Girard; Helen Trottier; Fatima Kakkar; Hugo Soudeyns; Marc Boucher; Normand Lapointe; Isabelle Boucoiran
Journal:  BMC Pregnancy Childbirth       Date:  2019-12-09       Impact factor: 3.007

7.  Postoperative infectious morbidities of cesarean delivery in human immunodeficiency virus-infected women.

Authors:  Helen Cavasin; Thao Dola; Olga Uribe; Manoj Biswas; Mai Do; Azad Bhuiyan; MarkAlain Dery; Chi Dola
Journal:  Infect Dis Obstet Gynecol       Date:  2009-05-25

8.  Gender inequities in quality of care among HIV-positive individuals initiating antiretroviral treatment in British Columbia, Canada (2000-2010).

Authors:  Allison Carter; Jeong Eun Min; William Chau; Viviane D Lima; Mary Kestler; Neora Pick; Deborah Money; Julio S G Montaner; Robert S Hogg; Angela Kaida
Journal:  PLoS One       Date:  2014-03-18       Impact factor: 3.240

Review 9.  Antiviral and antiretroviral use in pregnancy.

Authors:  Deborah M Money
Journal:  Obstet Gynecol Clin North Am       Date:  2003-12       Impact factor: 2.844

10.  Mode of delivery in HIV-infected pregnant women and prevention of mother-to-child transmission: changing practices in Western Europe.

Authors:  K Boer; K England; M H Godfried; C Thorne
Journal:  HIV Med       Date:  2010-01-04       Impact factor: 3.180

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.